J. Mezger

4.8k citations
53 papers · 3.4k · 2 hit papers · h-index 18

Impact in

Papers in

    • Lung Cancer Research Studies 13
    • Cancer Treatment and Pharmacology 6
    • Lung Cancer Treatments and Mutations 16
    • Pleural and Pulmonary Diseases 6
    • Medical Imaging and Pathology Studies 6
    • Occupational and environmental lung diseases 5

J. Mezger

50 papers receiving 3.3k citations

J. Mezger's Hit Papers

Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL) 2010 · 498 citations
4980+5+11Years since publication2505007501000

Peers

J. Mezger
Comparison fields: 5 of 94
  • Oncology 1.9k
  • Pulmonary and Respiratory Medicine 1.7k
  • Pathology and Forensic Medicine 451
  • Cancer Research 351
  • Hepatology 183
Replace Alessandra Bearz with:
Alessandra Bearz Italy
Hirohito Tada Japan
Enrico Aitini Italy
Marco Alloisio Italy
Fadi Braiteh United States
José M. López-Picazo Spain
Dominique Grunenwald France
Takeshi Hanagiri Japan
Kazuhiro Sakamoto Japan
Dae Young Zang South Korea
J. Mezger relative to Alessandra Bearz Italy Alessandra Bearz's profile →
Citations per field
00.5×1.6×
Alessandra Bearz · 1×
Citations per year

Countries citing papers authored by J. Mezger

Since Specialization
Citations

This map shows the geographic impact of J. Mezger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Mezger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Mezger more than expected).

Fields of papers citing papers by J. Mezger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Mezger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Mezger. The network helps show where J. Mezger may publish in the future.

Co-authors

The 25 scholars most cited alongside J. Mezger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Mezger Line = papers co-authored together J. Mezger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiL
Hit paper breakdown →
20091174
2
Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)
Hit paper breakdown →
2010498
3 2003367
4 2003294
5 2014232
6 2008129
7 201082
8 200252
9 199848
10 198846
11 201140
12 200235
13 199930
14 201430
15 201728
16 199026
17
Identification of carcinoma cells in ascitic and pleural fluid. Comparison of four panepithelial antigens with carcinoembryonic antigen.
199223
18 198622
19 199617
20 200017

About J. Mezger

J. Mezger is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Epidemiology, having authored 53 papers that have together received 3.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (13 papers), Cancer Treatment and Pharmacology (6 papers), Pleural and Pulmonary Diseases (6 papers), Medical Imaging and Pathology Studies (6 papers), Cancer therapeutics and mechanisms (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers) and Occupational and environmental lung diseases (5 papers). The work is most often cited by research in Oncology (1.9k citations), Pulmonary and Respiratory Medicine (1.7k citations), Pathology and Forensic Medicine (451 citations), Cancer Research (351 citations) and Hepatology (183 citations). J. Mezger has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Joachim von Pawel, Martin Reck, Rodryg Ramlau, Vera Hirsh, Petr Zatloukal, Venice Archer, Christian Manegold, N. Moore, Natasha B. Leighl and Vera Gorbounova. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, Annals of Oncology, Clinical Lung Cancer and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact